ClinicalTrials.Veeva

Menu

Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

B

Bangkok Metropolitan Administration Medical College and Vajira Hospital

Status

Completed

Conditions

Chronic Kidney Disease

Treatments

Other: Measure plasma and dialysate level of IL-6, procalcitonin and VEGF

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of study was to evaluated the correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Full description

This cross -sectional study measured IL-6, procalcitonin and VEGF level in plasma and overnight effluent. PSTR of small solutes was evaluated by standard peritoneal equilibration test (standard PET). Weekly Kt/V and creatinine clearance (CCr ) were evaluated in all patients.

Enrollment

26 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable CAPD patients without previous history of peritonitis

Exclusion criteria

  • HIV
  • Other infections, tuberculosis or on immunosuppressive drugs,
  • Autoimmune disease,
  • Cancer
  • Diagnosis of permanent ultrafiltration failure .

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems